Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7807

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-7807). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatinfigure1 (Atorvastatinfigure1)

Chemical structure of atorvastatin calcium showing the molecular arrangement including multiple phenyl groups, hydroxyl groups, and calcium ion with three hydrate molecules.*

FDA Label Image

Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)

A line chart comparing cumulative incidence percentages over a period of 3.5 years between Atorvastatin and Placebo groups. The chart shows higher cumulative incidence in the Placebo group, with Atorvastatin displaying a lower incidence rate. The hazard ratio is noted as 0.64 (0.50-0.83) with a p-value of 0.0005.*

FDA Label Image

Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)

A cumulative hazard graph comparing atorvastatin versus placebo over five years, showing time to first primary endpoint. The x-axis represents years of follow-up (up to 5), and the y-axis shows cumulative hazard percentage (0 to 15%). The graph includes two lines: one solid for atorvastatin and one dashed for placebo, with atorvastatin showing consistently lower hazard. Additional text shows hazard ratio (HR) 0.63 (0.48-0.83) and p-value 0.001.*

FDA Label Image

Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)

A line graph depicting the percentage of subjects experiencing a major cardiovascular event over a five-year period for Atorvastatin 10 mg and 80 mg doses. The graph compares event incidence over time, illustrating different risk levels between doses, with statistical values for hazard ratio and p-value indicated.*

FDA Label Image

Label Image (Lbl500907807)

Label for ATORVASTATIN CALCIUM 40 mg film-coated tablets by A-S Medication Solutions. The label indicates the product is oral dosage form with 90 tablets per package. It shows storage instructions to keep between 68 to 77 degrees Fahrenheit and includes an NDC of 50090-7807-0 along with a QR code and barcode for scanning.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.